Lushang Freda Pharmaceutical (SH:600223) FBeauty未来迹·2025-08-12 11:36Core Viewpoint - The article highlights the successful launch of the "287 Barrier Technology" series by Yal Doctor, achieving over 10 million in sales within 50 days, driven by a strong focus on long-term research and development rather than short-term marketing tactics [3][16]. Group 1: Research and Development Strategy - Yal Doctor has established a unique research moat in the field of skin microbiome, focusing on Chinese skin characteristics since its inception in 2018, with foundational research dating back to 2015 [6][8]. - The brand's research team has collected over 10,000 skin microbiome samples from various regions in China, creating the first "Chinese Healthy Skin Microbiome Resource Bank" with over 2,000 core strains identified [7][9]. - Yal Doctor has built a comprehensive platform system for research, application, product development, and efficacy evaluation, supported by two major databases [7][9]. Group 2: Product Development and Market Launch - The "287 Barrier Technology" was developed based on the identification of a specific strain, CCSM0287, which exhibits exceptional barrier repair capabilities and has been patented [10][11]. - The new product line, including masks and lotions, was launched with a focus on user experience and scientific backing, leading to rapid market acceptance and positive consumer feedback [12][16]. - The brand's sales strategy emphasizes a "research first, marketing later" approach, ensuring that products are backed by solid scientific evidence before reaching consumers [8][18]. Group 3: Market Position and Future Outlook - Yal Doctor has positioned itself as a leader in the skin microbiome skincare sector, transitioning from a pioneer to a market leader through substantial research investments and a systematic operational approach [8][15]. - The successful market performance of the "287 Barrier Technology" series reflects the brand's ability to convert research into profitable products, establishing a sustainable business model [16][19]. - As consumer acceptance of microbiome skincare grows, Yal Doctor is expected to enhance its influence in both the Chinese and global markets, potentially setting new industry standards [20].